CoChat

Endogenous Double-Stranded RNA

Sadeq, Shaymaa, Al-Hashimi, Surar, Cusack, Carmen M., Werner, Andreas · 2021 · Non-Coding RNA
Cited by 70

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The birth of long non-coding RNAs (lncRNAs) is closely associated with the presence and activation of repetitive elements in the genome. The transcription of endogenous retroviruses as well as long and short interspersed elements is not only essential for evolving lncRNAs but is also a significant source of double-stranded RNA (dsRNA). From an lncRNA-centric point of view, the latter is a minor source of bother in the context of the entire cell; however, dsRNA is an essential threat. A viral infection is associated with cytoplasmic dsRNA, and endogenous RNA hybrids only differ from viral dsRNA by the 5′ cap structure. Hence, a multi-layered defense network is in place to protect cells from viral infections but tolerates endogenous dsRNA structures. A first line of defense is established with compartmentalization; whereas endogenous dsRNA is found predominantly confined to the nucleus and the mitochondria, exogenous dsRNA reaches the cytoplasm. Here, various sensor proteins recognize features of dsRNA including the 5′ phosphate group of viral RNAs or hybrids with a particular length but not specific nucleotide sequences. The sensors trigger cellular stress pathways and innate immunity via interferon signaling but also induce apoptosis via caspase activation. Because of its central role in viral recognition and immune activation, dsRNA sensing is implicated in autoimmune diseases and used to treat cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ncrna7010015

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic representation of repetitive elements in the human genome associated with double-stranded RNA (dsRNA) formation. LINE 1 and endogenous retroviruses (ERVs) give potential rise to long dsRNA structures formed from convergent transcripts or hairpin structures from read-through transcription of head-to-head/tail-to-tail arranged elements. Alu elements are much shorter and form hairpin structures as well as “open” dsRNA hybrids, though the intermolecular duplexes are rare. Alu elements are the predominant target for adenosine deaminase acting on RNA (ADAR)-mediated adenosine-to-inosine (A-to-I) editing. LTRs function as bi-directional promoters. ORF, open reading frame; GAG (group specific antigen), POL (reverse transcriptase), ENV (envelope protein), retroviral proteins; UTR, untranslated region; LTR, long terminal repeat. Figure created with Biorender.com.
Figure 1 Schematic representation of repetitive elements in the human genome associated with double-stranded RNA (dsRNA) formation. LINE 1 and endogenous retroviruses (ERVs) give potential rise to long dsRNA structures formed from convergent transcripts or hairpin structures from read-through transcription of head-to-head/tail-to-tail arranged elements. Alu elements are much shorter and form hairpin structures as well as “open” dsRNA hybrids, though the intermolecular duplexes are rare. Alu elements are the predominant target for adenosine deaminase acting on RNA (ADAR)-mediated adenosine-to-inosine (A-to-I) editing. LTRs function as bi-directional promoters. ORF, open reading frame; GAG (group specific antigen), POL (reverse transcriptase), ENV (envelope protein), retroviral proteins; UTR, untranslated region; LTR, long terminal repeat. Figure created with Biorender.com.CC BY · PubMed Central
Figure 2 Double-stranded RNA (dsRNA) formation from sense–antisense transcripts. Natural antisense transcripts are processed and potentially reach the cytoplasm, where they interact with the sense transcript. In somatic cells, the level of sense–antisense hybrids is low, and there is no evidence of ADAR editing, for example, nor is dsRNA immune signaling triggered. Various mechanisms (RNA interference, RNA masking, RNA editing and dsRNA signaling) are potentially triggered by the dsRNA, depending on the cellular context. In male germ cells and during early embryogenesis, sense–antisense dsRNA formation may play a general, system-relevant role. Figure created with Biorender.com.
Figure 2 Double-stranded RNA (dsRNA) formation from sense–antisense transcripts. Natural antisense transcripts are processed and potentially reach the cytoplasm, where they interact with the sense transcript. In somatic cells, the level of sense–antisense hybrids is low, and there is no evidence of ADAR editing, for example, nor is dsRNA immune signaling triggered. Various mechanisms (RNA interference, RNA masking, RNA editing and dsRNA signaling) are potentially triggered by the dsRNA, depending on the cellular context. In male germ cells and during early embryogenesis, sense–antisense dsRNA formation may play a general, system-relevant role. Figure created with Biorender.com.CC BY · PubMed Central
Figure 3 Double-stranded RNA (dsRNA) sensor proteins and activation of innate immunity. Viral dsRNA (including 5′ phosphorylation) or dsRNA from mitochondria and repetitive elements in the cytoplasm are recognized by dsRNA sensors retinoic acid-inducible gene I (RIG1), melanoma differentiation-associated gene 5 (MDA5), protein kinase R (PKR) and ADAR. RIG1 requires the 5′ phosphate group to initiate oligomerization, and MDA5 forms long dsRNA-dependent polymers. Both structures induce mitochondrial antiviral signaling (MAVS) polymerization and, eventually, caspase and interferon signaling. PKR binds short dsRNA molecules, dimerizes and becomes activated through autophosphorylation. Activated PKR dissociates from dsRNA, phosphorylates eukaryotic initiation factor 2α (eIF2α) (which, in turn, inhibits translation globally) and triggers an interferon response. ADAR is present in both the nucleus and cytoplasm and antagonizes dsRNA signaling by melting the RNA hybrid. Figure created with Biorender.com.
Figure 3 Double-stranded RNA (dsRNA) sensor proteins and activation of innate immunity. Viral dsRNA (including 5′ phosphorylation) or dsRNA from mitochondria and repetitive elements in the cytoplasm are recognized by dsRNA sensors retinoic acid-inducible gene I (RIG1), melanoma differentiation-associated gene 5 (MDA5), protein kinase R (PKR) and ADAR. RIG1 requires the 5′ phosphate group to initiate oligomerization, and MDA5 forms long dsRNA-dependent polymers. Both structures induce mitochondrial antiviral signaling (MAVS) polymerization and, eventually, caspase and interferon signaling. PKR binds short dsRNA molecules, dimerizes and becomes activated through autophosphorylation. Activated PKR dissociates from dsRNA, phosphorylates eukaryotic initiation factor 2α (eIF2α) (which, in turn, inhibits translation globally) and triggers an interferon response. ADAR is present in both the nucleus and cytoplasm and antagonizes dsRNA signaling by melting the RNA hybrid. Figure created with Biorender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 141

  1. de Koning A.P. Gu W. Castoe T.A. Batzer M.A. Pollock D.D. Repetitive elements may comprise over two-thirds of the human genome PLoS Genet. 2011 7 e1002384 10.1371/journal.pgen.1002384 22144907 PMC3228813 · DOI · Paper page
  2. Haubold B. Wiehe T. How repetitive are genomes? BMC Bioinform. 2006 7 541 10.1186/1471-2105-7-541 PMC1769404 17187668 · DOI · Paper page
  3. Kidwell M.G. Lisch D.R. Transposable elements and host genome evolution Trends Ecol. Evol. 2000 15 95 99 10.1016/S0169-5347(99)01817-0 10675923 · DOI · Paper page
  4. Ohno S. So much “junk” DNA in our genome Brookhaven Symp. Biol. 1972 23 366 370 5065367
  5. Clark M.B. Amaral P.P. Schlesinger F.J. Dinger M.E. Taft R.J. Rinn J.L. Ponting C.P. Stadler P.F. Morris K.V. Morillon A. The Reality of Pervasive Transcription PLoS Biol. 2011 9 e1000625 10.1371/journal.pbio.1000625 21765801 PMC3134446 · DOI · Paper page
  6. Lu J.Y. Shao W. Chang L. Yin Y. Li T. Zhang H. Hong Y. Percharde M. Guo L. Wu Z. Genomic Repeats Categorize Genes with Distinct Functions for Orchestrated Regulation Cell Rep. 2020 30 3296 3311.e5 10.1016/j.celrep.2020.02.048 32160538 PMC7195444 · DOI · Paper page
  7. Dinger M.E. Amaral P.P. Mercer T.R. Mattick J.S. Pervasive transcription of the eukaryotic genome: Functional indices and conceptual implications Brief. Funct. Genom. Proteom. 2009 8 407 423 10.1093/bfgp/elp038 19770204 · DOI · Paper page
  8. Ponting C.P. Belgard T.G. Transcribed dark matter: Meaning or myth? Hum. Mol. Genet. 2010 19 R162 R168 10.1093/hmg/ddq362 20798109 PMC2953743 · DOI · Paper page
  9. Palazzo A.F. Koonin E.V. Functional Long Non-coding RNAs Evolve from Junk Transcripts Cell 2020 183 1151 1161 10.1016/j.cell.2020.09.047 33068526 · DOI · Paper page
  10. Ganesh S. Svoboda P. Retrotransposon-associated long non-coding RNAs in mice and men Pflug. Arch 2016 468 1049 1060 10.1007/s00424-016-1818-5 27044413 · DOI
  11. Achour C. Aguilo F. Long non-coding RNA and Polycomb: An intricate partnership in cancer biology Front. Biosci. (Landmark Ed.) 2018 23 2106 2132 29772549 · doi:10.2741/4693
  12. Rinn J.L. Kertesz M. Wang J.K. Squazzo S.L. Xu X. Brugmann S.A. Goodnough L.H. Helms J.A. Farnham P.J. Segal E. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs Cell 2007 129 1311 1323 10.1016/j.cell.2007.05.022 17604720 PMC2084369 · DOI · Paper page
  13. Fabbri M. Girnita L. Varani G. Calin G.A. Decrypting noncoding RNA interactions, structures, and functional networks Genome Res. 2019 29 1377 1388 10.1101/gr.247239.118 31434680 PMC6724670 · DOI · Paper page
  14. Barak M. Porath H.T. Finkelstein G. Knisbacher B.A. Buchumenski I. Roth S.H. Levanon E.Y. Eisenberg E. Purifying selection of long dsRNA is the first line of defense against false activation of innate immunity Genome Biol. 2020 21 26 10.1186/s13059-020-1937-3 32028986 PMC7006430 · DOI
  15. Cohen-Fultheim R. Levanon E.Y. Detection of A-to-I Hyper-edited RNA Sequences RNA Editing: Methods and Protocols Picardi E. Pesole G. Springer New York, NY, USA 2021 213 227 10.1007/978-1-0716-0787-9_13 32729083 · DOI
  16. Molder T. Speek M. [Letter to the Editor] Accelerated RNA-RNA hybridization by concentrated guanidinium thiocyanate solution in single-step RNA isolation BioTechniques 2016 61 61 65 10.2144/000114441 27528070 · DOI
  17. Aloni Y. Attardi G. Symmetrical in vivo transcription of mitochondrial DNA in HeLa cells Proc. Natl. Acad. Sci. USA 1971 68 1757 1761 10.1073/pnas.68.8.1757 5288761 PMC389287 · DOI · Paper page
  18. Young P.G. Attardi G. Characterization of double-stranded RNA from HeLa cell mitochondria Biochem. Biophys. Res. Commun. 1975 65 1201 1207 10.1016/S0006-291X(75)80357-3 1052421 · DOI
  19. Krishnan K.J. Turnbull D.M. Mitochondrial DNA and genetic disease Essays Biochem. 2010 47 139 151 10.1042/bse0470139 20533905 · DOI
  20. Borowski L.S. Dziembowski A. Hejnowicz M.S. Stepien P.P. Szczesny R.J. Human mitochondrial RNA decay mediated by PNPase-hSuv3 complex takes place in distinct foci Nucleic Acids Res. 2013 41 1223 1240 10.1093/nar/gks1130 23221631 PMC3553951 · DOI · Paper page
  21. Pajak A. Laine I. Clemente P. El-Fissi N. Schober F.A. Maffezzini C. Calvo-Garrido J. Wibom R. Filograna R. Dhir A. Defects of mitochondrial RNA turnover lead to the accumulation of double-stranded RNA in vivo PLoS Genet. 2019 15 e1008240 10.1371/journal.pgen.1008240 31365523 PMC6668790 · DOI · Paper page
  22. Rius R. Van Bergen N.J. Compton A.G. Riley L.G. Kava M.P. Balasubramaniam S. Amor D.J. Fanjul-Fernandez M. Cowley M.J. Fahey M.C. Clinical Spectrum and Functional Consequences Associated with Bi-Allelic Pathogenic PNPT1 Variants J. Clin. Med. 2019 8 2020 10.3390/jcm8112020 PMC6912252 31752325 · DOI
  23. Kim Y. Park J. Kim S. Kim M. Kang M.G. Kwak C. Kang M. Kim B. Rhee H.W. Kim V.N. PKR Senses Nuclear and Mitochondrial Signals by Interacting with Endogenous Double-Stranded RNAs Mol. Cell 2018 71 1051 1063.e6 10.1016/j.molcel.2018.07.029 30174290 · DOI · Paper page
  24. Arnaiz E. Miar A. Dias A.G. Prasad N. Schulze U. Waithe D. Rehwinkel J. Harris A. Hypoxia regulates endogenous double-stranded RNA production via reduced mitochondrial DNA transcription bioRxiv 2020 10.1101/2020.07.31.230300 PMC8651540 34900733 · doi:10.1101/2020.07.31.230300
  25. Porath H.T. Knisbacher B.A. Eisenberg E. Levanon E.Y. Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance Genome Biol. 2017 18 185 10.1186/s13059-017-1315-y 28969707 PMC5625713 · DOI · Paper page
  26. Reich D.P. Bass B.L. Mapping the dsRNA World Cold Spring Harb. Perspect. Biol. 2019 11 10.1101/cshperspect.a035352 30824577 PMC6396333 · DOI · Paper page
  27. Quentin Y. Origin of the Alu family: A family of Alu-like monomers gave birth to the left and the right arms of the Alu elements Nucleic Acids Res. 1992 20 3397 3401 10.1093/nar/20.13.3397 1378589 PMC312495 · DOI · Paper page
  28. Deininger P. Alu elements: Know the SINEs Genome Biol. 2011 12 236 10.1186/gb-2011-12-12-236 22204421 PMC3334610 · DOI · Paper page
  29. Ullu E. Tschudi C. Alu sequences are processed 7SL RNA genes Nature 1984 312 171 172 10.1038/312171a0 6209580 · DOI · Paper page
  30. Batzer M.A. Deininger P.L. Alu repeats and human genomic diversity Nat. Rev. 2002 3 370 379 10.1038/nrg798 11988762 · DOI · Paper page
  31. Li T.-H. Schmid C.W. Differential stress induction of individual Alu loci: Implications for transcription and retrotransposition Gene 2001 276 135 141 10.1016/S0378-1119(01)00637-0 11591480 · DOI
  32. Berger A. Strub K. Multiple Roles of Alu-Related Noncoding RNAs Prog. Mol. Subcell. Biol. 2011 51 119 146 10.1007/978-3-642-16502-3_6 21287136 · DOI
  33. Caudron-Herger M. Pankert T. Seiler J. Németh A. Voit R. Grummt I. Rippe K. Alu element-containing RNAs maintain nucleolar structure and function EMBO J. 2015 34 2758 2774 10.15252/embj.201591458 26464461 PMC4682651 · DOI · Paper page
  34. Bazak L. Levanon E.Y. Eisenberg E. Genome-wide analysis of Alu editability Nucleic Acids Res. 2014 42 6876 6884 10.1093/nar/gku414 24829451 PMC4066801 · DOI · Paper page
  35. Kawahara Y. Nishikura K. Extensive adenosine-to-inosine editing detected in Alu repeats of antisense RNAs reveals scarcity of sense-antisense duplex formation FEBS Lett. 2006 580 2301 2305 10.1016/j.febslet.2006.03.042 16574103 PMC2944036 · DOI
  36. Zhang M. Liang J.Q. Zheng S. Expressional activation and functional roles of human endogenous retroviruses in cancers Rev. Med Virol. 2019 29 e2025 10.1002/rmv.2025 30614117 PMC6590502 · DOI · Paper page
  37. Hurst T.P. Magiorkinis G. Activation of the innate immune response by endogenous retroviruses J. Gen. Virol 2015 96 1207 1218 10.1099/vir.0.000017 26068187 · doi:10.1099/vir.0.000017 · Paper page
  38. Di Cristofano A. Strazzullo M. Longo L. La Mantia G. Characterization and genomic mapping of the ZNF80 locus: Expression of this zinc-finger gene is driven by a solitary LTR of ERV9 endogenous retroviral family Nucleic Acids Res. 1995 23 2823 2830 10.1093/nar/23.15.2823 7659503 PMC307117 · DOI · Paper page
  39. Domansky A.N. Kopantzev E.P. Snezhkov E.V. Lebedev Y.B. Leib-Mosch C. Sverdlov E.D. Solitary HERV-K LTRs possess bi-directional promoter activity and contain a negative regulatory element in the U5 region FEBS Lett. 2000 472 191 195 10.1016/S0014-5793(00)01460-5 10788609 · DOI · Paper page
  40. Strick R. Strissel P.L. Baylin S.B. Chiappinelli K.B. Unraveling the molecular pathways of DNA-methylation inhibitors: Human endogenous retroviruses induce the innate immune response in tumors Oncoimmunology 2016 5 e1122160 10.1080/2162402X.2015.1122160 27467919 PMC4910697 · DOI · Paper page
  41. Roulois D. Loo Yau H. Singhania R. Wang Y. Danesh A. Shen S.Y. Han H. Liang G. Jones P.A. Pugh T.J. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts Cell 2015 162 961 973 10.1016/j.cell.2015.07.056 26317465 PMC4843502 · DOI · Paper page
  42. Richardson S.R. Doucet A.J. Kopera H.C. Moldovan J.B. Garcia-Perez J.L. Moran J.V. The Influence of LINE-1 and SINE Retrotransposons on Mammalian Genomes Microbiol. Spectr. 2015 3 1165 1208 10.1128/microbiolspec.MDNA3-0061-2014 PMC4498412 26104698 · DOI · Paper page
  43. Martin S.L. The ORF1 protein encoded by LINE-1: Structure and function during L1 retrotransposition J. Biomed. Biotechnol. 2006 2006 45621 10.1155/JBB/2006/45621 16877816 PMC1510943 · DOI · Paper page
  44. Faulkner G.J. Billon V. L1 retrotransposition in the soma: A field jumping ahead Mob. DNA 2018 9 22 10.1186/s13100-018-0128-1 30002735 PMC6035798 · DOI · Paper page
  45. Kim S. Ku Y. Ku J. Kim Y. Evidence of Aberrant Immune Response by Endogenous Double-Stranded RNAs: Attack from Within Bioessays 2019 41 e1900023 10.1002/bies.201900023 31099409 · DOI
  46. Bahn J.H. Ahn J. Lin X. Zhang Q. Lee J.-H. Civelek M. Xiao X. Genomic analysis of ADAR1 binding and its involvement in multiple RNA processing pathways Nat. Commun. 2015 6 6355 10.1038/ncomms7355 25751603 PMC4355961 · DOI · Paper page
  47. Orecchini E. Doria M. Antonioni A. Galardi S. Ciafrè S.A. Frassinelli L. Mancone C. Montaldo C. Tripodi M. Michienzi A. ADAR1 restricts LINE-1 retrotransposition Nucleic Acids Res. 2017 45 155 168 10.1093/nar/gkw834 27658966 PMC5224506 · DOI · Paper page
  48. Balbin O.A. Malik R. Dhanasekaran S.M. Prensner J.R. Cao X. Wu Y.M. Robinson D. Wang R. Chen G. Beer D.G. The landscape of antisense gene expression in human cancers Genome Res. 2015 25 1068 1079 10.1101/gr.180596.114 26063736 PMC4484389 · DOI · Paper page
  49. Katayama S. Tomaru Y. Kasukawa T. Waki K. Nakanishi M. Nakamura M. Nishida H. Yap C.C. Suzuki M. Kawai J. Antisense transcription in the mammalian transcriptome Science 2005 309 1564 1566 16141073 · DOI · Paper page
  50. Sleutels F. Zwart R. Barlow D.P. The non-coding Air RNA is required for silencing autosomal imprinted genes Nature 2002 415 810 813 10.1038/415810a 11845212 · DOI · Paper page
  51. Thakur N. Tiwari V.K. Thomassin H. Pandey R.R. Kanduri M. Gondor A. Grange T. Ohlsson R. Kanduri C. An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region Mol. Cell. Biol. 2004 24 7855 7862 10.1128/MCB.24.18.7855-7862.2004 15340049 PMC515059 · DOI · Paper page
  52. Tufarelli C. Frischauf A.M. Hardison R. Flint J. Higgs D.R. Characterization of a widely expressed gene (LUC7-LIKE; LUC7L) defining the centromeric boundary of the human alpha-globin domain Genomics 2001 71 307 314 10.1006/geno.2000.6394 11170747 · DOI
  53. Wong I.H. Lo Y.M. Yeo W. Lau W.Y. Johnson P.J. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2000 6 3516 3521 10999738
  54. Yu W. Gius D. Onyango P. Muldoon-Jacobs K. Karp J. Feinberg A.P. Cui H. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA Nature 2008 451 202 206 10.1038/nature06468 18185590 PMC2743558 · DOI · Paper page
  55. Chen J. Sun M. Kent W.J. Huang X. Xie H. Wang W. Zhou G. Shi R.Z. Rowley J.D. Over 20% of human transcripts might form sense-antisense pairs Nucleic Acids Res. 2004 32 4812 4820 10.1093/nar/gkh818 15356298 PMC519112 · DOI · Paper page
  56. Kiyosawa H. Yamanaka I. Osato N. Kondo S. Hayashizaki Y. Antisense transcripts with FANTOM2 clone set and their implications for gene regulation Genome Res. 2003 13 1324 1334 10.1101/gr.982903 12819130 PMC403655 · DOI · Paper page
  57. Wight M. Werner A. The functions of natural antisense transcripts Essays Biochem. 2013 54 91 101 10.1042/bse0540091 23829529 PMC4284957 · DOI
  58. Faghihi M.A. Wahlestedt C. Regulatory roles of natural antisense transcripts Nat. Rev. Mol. Cell Biol. 2009 10 637 643 10.1038/nrm2738 19638999 PMC2850559 · DOI · Paper page
  59. Zinad H.S. Natasya I. Werner A. Natural Antisense Transcripts at the Interface between Host Genome and Mobile Genetic Elements Front. Microbiol. 2017 8 2292 10.3389/fmicb.2017.02292 29209299 PMC5701935 · DOI
  60. Faghihi M.A. Zhang M. Huang J. Modarresi F. Van der Brug M.P. Nalls M.A. Cookson M.R. St-Laurent G. 3rd Wahlestedt C. Evidence for natural antisense transcript-mediated inhibition of microRNA function Genome Biol. 2010 11 R56 10.1186/gb-2010-11-5-r56 20507594 PMC2898074 · DOI · Paper page
  61. Piatek M.J. Henderson V. Zynad H.S. Werner A. Natural antisense transcription from a comparative perspective Genomics 2016 10.1016/j.ygeno.2016.05.004 PMC4996343 27241791 · DOI
  62. Jadaliha M. Gholamalamdari O. Tang W. Zhang Y. Petracovici A. Hao Q. Tariq A. Kim T.G. Holton S.E. Singh D.K. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability PLoS Genet. 2018 14 e1007802 10.1371/journal.pgen.1007802 30496290 PMC6289468 · DOI
  63. Deng S.J. Chen H.Y. Zeng Z. Deng S. Zhu S. Ye Z. He C. Liu M.L. Huang K. Zhong J.X. Nutrient Stress-Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression Cancer Res. 2019 79 1398 1412 10.1158/0008-5472.CAN-18-0419 30563888 · DOI
  64. Werner A. Cockell S. Falconer J. Carlile M. Alnumeir S. Robinson J. Contribution of natural antisense transcription to an endogenous siRNA signature in human cells BMC Genom. 2014 15 19 10.1186/1471-2164-15-19 PMC3898206 24410956 · DOI
  65. Piatek M.J. Henderson V. Fearn A. Chaudhry B. Werner A. Ectopically expressed Slc34a2a sense-antisense transcripts cause a cerebellar phenotype in zebrafish embryos depending on RNA complementarity and Dicer PLoS ONE 2017 12 e0178219 10.1371/journal.pone.0178219 28542524 PMC5436864 · DOI
  66. Dahary D. Elroy-Stein O. Sorek R. Naturally occurring antisense: Transcriptional leakage or real overlap? Genome Res. 2005 15 364 368 10.1101/gr.3308405 15710751 PMC551562 · DOI · Paper page
  67. Pillay S. Takahashi H. Carninci P. Kanhere A. Antisense ncRNAs during early vertebrate development are divided in groups with distinct features bioRxiv 2020 10.1101/2020.02.08.940148 PMC8168585 33795334 · DOI
  68. Goll M.G. Halpern M.E. DNA methylation in zebrafish Prog. Mol. Biol. Transl. Sci. 2011 101 193 218 10.1016/b978-0-12-387685-0.00005-6 21507352 PMC5455991 · DOI
  69. Morgan H.D. Santos F. Green K. Dean W. Reik W. Epigenetic reprogramming in mammals Hum. Mol. Genet. 2005 14 R47 R58 10.1093/hmg/ddi114 15809273 · DOI · Paper page
  70. Li N. Wang T. Han D. Structural, cellular and molecular aspects of immune privilege in the testis Front. Immunol. 2012 3 152 10.3389/fimmu.2012.00152 22701457 PMC3371599 · DOI · Paper page
  71. Nejepinska J. Malik R. Filkowski J. Flemr M. Filipowicz W. Svoboda P. dsRNA expression in the mouse elicits RNAi in oocytes and low adenosine deamination in somatic cells Nucleic Acids Res. 2012 40 399 413 10.1093/nar/gkr702 21908396 PMC3245926 · DOI
  72. Song R. Hennig G.W. Wu Q. Jose C. Zheng H. Yan W. Male germ cells express abundant endogenous siRNAs Proc. Natl. Acad. Sci. USA 2011 108 13159 13164 10.1073/pnas.1108567108 21788498 PMC3156200 · DOI · Paper page
  73. Watanabe T. Totoki Y. Toyoda A. Kaneda M. Kuramochi-Miyagawa S. Obata Y. Chiba H. Kohara Y. Kono T. Nakano T. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes Nature 2008 453 539 543 10.1038/nature06908 18404146 · DOI · Paper page
  74. Masliah G. Barraud P. Allain F.H. RNA recognition by double-stranded RNA binding domains: A matter of shape and sequence Cell. Mol. Life Sci. 2013 70 1875 1895 10.1007/s00018-012-1119-x 22918483 PMC3724394 · DOI · Paper page
  75. Stefl R. Oberstrass F.C. Hood J.L. Jourdan M. Zimmermann M. Skrisovska L. Maris C. Peng L. Hofr C. Emeson R.B. The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove Cell 2010 143 225 237 10.1016/j.cell.2010.09.026 20946981 PMC2956598 · DOI · Paper page
  76. Yadav D.K. Zigáčková D. Zlobina M. Klumpler T. Beaumont C. Kubíčková M. Vaňáčová Š. Lukavsky P.J. Staufen1 reads out structure and sequence features in ARF1 dsRNA for target recognition Nucleic Acids Res. 2020 48 2091 2106 10.1093/nar/gkz1163 31875226 PMC7038937 · DOI
  77. Kawasaki T. Kawai T. Akira S. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity Immunol. Rev. 2011 243 61 73 10.1111/j.1600-065X.2011.01048.x 21884167 PMC7165622 · DOI · Paper page
  78. Matz K.M. Guzman R.M. Goodman A.G. The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders Int. Rev. Cell Mol. Biol. 2019 345 35 136 10.1016/bs.ircmb.2018.08.002 30904196 PMC6445394 · DOI
  79. Zhu Z. Zhang X. Wang G. Zheng H. The laboratory of genetics and physiology 2: Emerging insights into the controversial functions of this RIG-I-like receptor BioMed Res. Int. 2014 2014 960190 10.1155/2014/960190 24551857 PMC3914343 · DOI
  80. Cui J. Chen Y. Wang H.Y. Wang R.F. Mechanisms and pathways of innate immune activation and regulation in health and cancer Hum. Vaccines Immunother. 2014 10 3270 3285 10.4161/21645515.2014.979640 PMC4514086 25625930 · DOI · Paper page
  81. Sohn J. Hur S. Filament assemblies in foreign nucleic acid sensors Curr. Opin. Struct. Biol. 2016 37 134 144 10.1016/j.sbi.2016.01.011 26859869 PMC5070476 · DOI · Paper page
  82. Kowalinski E. Lunardi T. McCarthy A.A. Louber J. Brunel J. Grigorov B. Gerlier D. Cusack S. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA Cell 2011 147 423 435 10.1016/j.cell.2011.09.039 22000019 · DOI · Paper page
  83. Schlee M. Roth A. Hornung V. Hagmann C.A. Wimmenauer V. Barchet W. Coch C. Janke M. Mihailovic A. Wardle G. Recognition of 5’ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus Immunity 2009 31 25 34 10.1016/j.immuni.2009.05.008 19576794 PMC2824854 · DOI · Paper page
  84. Peisley A. Jo M.H. Lin C. Wu B. Orme-Johnson M. Walz T. Hohng S. Hur S. Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments Proc. Natl. Acad. Sci. USA 2012 109 E3340 E3349 10.1073/pnas.1208618109 23129641 PMC3523859 · DOI · Paper page
  85. Reikine S. Nguyen J.B. Modis Y. Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5 Front. Immunol. 2014 5 342 10.3389/fimmu.2014.00342 25101084 PMC4107945 · DOI · Paper page
  86. Ren Z. Ding T. Zuo Z. Xu Z. Deng J. Wei Z. Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response Front. Immunol. 2020 11 1030 10.3389/fimmu.2020.01030 32536927 PMC7267026 · DOI · Paper page
  87. Chukwurah E. Farabaugh K.T. Guan B.J. Ramakrishnan P. Hatzoglou M. A tale of two proteins: PACT and PKR and their roles in inflammation FEBS J. 2021 10.1111/febs.15691 PMC9248962 33387379 · DOI · Paper page
  88. Toth A.M. Zhang P. Das S. George C.X. Samuel C.E. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase Prog. Nucleic Acid Res. Mol. Biol. 2006 81 369 434 10.1016/s0079-6603(06)81010-x 16891177 · DOI
  89. Bevilacqua P.C. Cech T.R. Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR Biochemistry 1996 35 9983 9994 10.1021/bi9607259 8756460 · DOI · Paper page
  90. Manche L. Green S.R. Schmedt C. Mathews M.B. Interactions between double-stranded RNA regulators and the protein kinase DAI Mol. Cell. Biol. 1992 12 5238 5248 10.1128/MCB.12.11.5238 1357546 PMC360457 · DOI · Paper page
  91. Cole J.L. Activation of PKR: An open and shut case? Trends Biochem. Sci. 2007 32 57 62 10.1016/j.tibs.2006.12.003 17196820 PMC2703476 · DOI
  92. Gal-Ben-Ari S. Barrera I. Ehrlich M. Rosenblum K. PKR: A Kinase to Remember Front. Mol. Neurosci. 2018 11 480 10.3389/fnmol.2018.00480 30686999 PMC6333748 · DOI · Paper page
  93. von Roretz C. Gallouzi I.E. Protein kinase RNA/FADD/caspase-8 pathway mediates the proapoptotic activity of the RNA-binding protein human antigen R (HuR) J. Biol. Chem. 2010 285 16806 16813 10.1074/jbc.M109.087320 20353946 PMC2878037 · DOI · Paper page
  94. Patterson J.B. Samuel C.E. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: Evidence for two forms of the deaminase Mol. Cell. Biol. 1995 15 5376 5388 10.1128/MCB.15.10.5376 7565688 PMC230787 · DOI · Paper page
  95. Walkley C.R. Li J.B. Rewriting the transcriptome: Adenosine-to-inosine RNA editing by ADARs Genome Biol. 2017 18 205 10.1186/s13059-017-1347-3 29084589 PMC5663115 · DOI · Paper page
  96. Mannion N. Arieti F. Gallo A. Keegan L.P. O’Connell M.A. New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins Biomolecules 2015 5 2338 2362 10.3390/biom5042338 26437436 PMC4693238 · DOI
  97. George C.X. Samuel C.E. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible Proc. Natl. Acad. Sci. USA 1999 96 4621 4626 10.1073/pnas.96.8.4621 10200312 PMC16382 · DOI · Paper page
  98. Hundley H.A. Bass B.L. ADAR editing in double-stranded UTRs and other noncoding RNA sequences Trends Biochem. Sci. 2010 35 377 383 10.1016/j.tibs.2010.02.008 20382028 PMC2897959 · DOI · Paper page
  99. Tan M.H. Li Q. Shanmugam R. Piskol R. Kohler J. Young A.N. Liu K.I. Zhang R. Ramaswami G. Ariyoshi K. Dynamic landscape and regulation of RNA editing in mammals Nature 2017 550 249 254 10.1038/nature24041 29022589 PMC5723435 · DOI · Paper page
  100. Hood J.L. Emeson R.B. Editing of neurotransmitter receptor and ion channel RNAs in the nervous system Curr. Top. Microbiol. Immunol. 2012 353 61 90 10.1007/82_2011_157 21796513 PMC4109139 · DOI · Paper page
  101. Stulić M. Jantsch M.F. Spatio-temporal profiling of Filamin A RNA-editing reveals ADAR preferences and high editing levels outside neuronal tissues RNA Biol. 2013 10 1611 1617 10.4161/rna.26216 24025532 PMC3866242 · DOI
  102. Oakes E. Anderson A. Cohen-Gadol A. Hundley H.A. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma J. Biol. Chem. 2017 292 4326 4335 10.1074/jbc.M117.779868 28167531 PMC5354488 · DOI · Paper page
  103. Pfaller C.K. Li Z. George C.X. Samuel C.E. Protein kinase PKR and RNA adenosine deaminase ADAR1: New roles for old players as modulators of the interferon response Curr. Opin. Immunol. 2011 23 573 582 10.1016/j.coi.2011.08.009 21924887 PMC3190076 · DOI · Paper page
  104. Yang S. Deng P. Zhu Z. Zhu J. Wang G. Zhang L. Chen A.F. Wang T. Sarkar S.N. Billiar T.R. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs J. Immunol. 2014 193 3436 3445 10.4049/jimmunol.1401136 25172485 PMC4169998 · DOI · Paper page
  105. Wang Q. Carmichael G.G. Effects of length and location on the cellular response to double-stranded RNA Microbiol. Mol. Biol. Rev. 2004 68 432 452 10.1128/MMBR.68.3.432-452.2004 15353564 PMC515255 · DOI
  106. Zhang Z. Carmichael G.G. The fate of dsRNA in the nucleus: A p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs Cell 2001 106 465 475 10.1016/S0092-8674(01)00466-4 11525732 · DOI · Paper page
  107. Jeffrey I.W. Kadereit S. Meurs E.F. Metzger T. Bachmann M. Schwemmle M. Hovanessian A.G. Clemens M.J. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells Exp. Cell Res. 1995 218 17 27 10.1006/excr.1995.1126 7737357 · DOI
  108. Kim Y. Lee J.H. Park J.E. Cho J. Yi H. Kim V.N. PKR is activated by cellular dsRNAs during mitosis and acts as a mitotic regulator Genes Dev. 2014 28 1310 1322 10.1101/gad.242644.114 24939934 PMC4066401 · DOI · Paper page
  109. Bennett R.L. Pan Y. Christian J. Hui T. May W.S. Jr. The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G1 arrest Cell Cycle 2012 11 407 417 10.4161/cc.11.2.18999 22214662 PMC3293386 · DOI
  110. Zhu A.S. Li A. Ratliff T.S. Melsom M. Garza L.A. After Skin Wounding, Noncoding dsRNA Coordinates Prostaglandins and Wnts to Promote Regeneration J. Investig. Dermatol. 2017 137 1562 1568 10.1016/j.jid.2017.03.023 28392344 PMC5483387 · doi:10.1016/j.jid.2017.03.023
  111. Kim D. Chen R. Sheu M. Kim N. Kim S. Islam N. Wier E.M. Wang G. Li A. Park A. Noncoding dsRNA induces retinoic acid synthesis to stimulate hair follicle regeneration via TLR3 Nat. Commun. 2019 10 2811 10.1038/s41467-019-10811-y 31243280 PMC6594970 · DOI
  112. Nelson A.M. Reddy S.K. Ratliff T.S. Hossain M.Z. Katseff A.S. Zhu A.S. Chang E. Resnik S.R. Page C. Kim D. dsRNA Released by Tissue Damage Activates TLR3 to Drive Skin Regeneration Cell Stem Cell 2015 17 139 151 10.1016/j.stem.2015.07.008 26253200 PMC4529957 · DOI · Paper page
  113. Stojanovich L. Marisavljevich D. Stress as a trigger of autoimmune disease Autoimmun. Rev. 2008 7 209 213 10.1016/j.autrev.2007.11.007 18190880 · DOI · Paper page
  114. Schur P.H. Stollar B.D. Steinberg A.D. Talal N. Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases Arthritis Rheum. 1971 14 342 347 10.1002/art.1780140304 4998028 · doi:10.1002/art.1780140304
  115. Baechler E.C. Batliwalla F.M. Karypis G. Gaffney P.M. Ortmann W.A. Espe K.J. Shark K.B. Grande W.J. Hughes K.M. Kapur V. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus Proc. Natl. Acad. Sci. USA 2003 100 2610 2615 10.1073/pnas.0337679100 12604793 PMC151388 · DOI · Paper page
  116. Bennett L. Palucka A.K. Arce E. Cantrell V. Borvak J. Banchereau J. Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood J. Exp. Med. 2003 197 711 723 10.1084/jem.20021553 12642603 PMC2193846 · DOI · Paper page
  117. Crow M.K. Kirou K.A. Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE Autoimmunity 2003 36 481 490 10.1080/08916930310001625952 14984025 · DOI · Paper page
  118. Fenando A. Firn K. Louissa S. Hussain A. Case of anti-MDA-5 positive dermatomyositis with rapidly progressive interstitial lung disease BMJ Case Rep. 2020 13 e235493 10.1136/bcr-2020-235493 PMC7213713 32354766 · doi:10.1136/bcr-2020-235493
  119. Cufi P. Dragin N. Weiss J.M. Martinez-Martinez P. De Baets M.H. Roussin R. Fadel E. Berrih-Aknin S. Le Panse R. Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis Ann. Neurol. 2013 73 281 293 10.1002/ana.23791 23280437 · DOI
  120. Rácz E. Prens E.P. Kant M. Florencia E. Jaspers N.G. Laman J.D. de Ridder D. van der Fits L. Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes Br. J. Dermatol. 2011 164 838 847 10.1111/j.1365-2133.2010.10169.x 21143460 · DOI
  121. Afshar M. Martinez A.D. Gallo R.L. Hata T.R. Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases J. Eur. Acad. Dermatol. Venereol. 2013 27 771 778 10.1111/j.1468-3083.2012.04582.x 22671985 PMC3443510 · DOI
  122. Shinohara M.M. Davis C. Olerud J. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C J. Drugs Dermatol. 2009 8 870 872 19746680
  123. Roth S.H. Danan-Gotthold M. Ben-Izhak M. Rechavi G. Cohen C.J. Louzoun Y. Levanon E.Y. Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus Cell Rep. 2018 23 50 57 10.1016/j.celrep.2018.03.036 29617672 PMC5905401 · DOI · Paper page
  124. Vlachogiannis N.I. Gatsiou A. Silvestris D.A. Stamatelopoulos K. Tektonidou M.G. Gallo A. Sfikakis P.P. Stellos K. Increased adenosine-to-inosine RNA editing in rheumatoid arthritis J. Autoimmun. 2020 106 102329 10.1016/j.jaut.2019.102329 31493964 PMC7479519 · DOI
  125. Paz-Yaacov N. Bazak L. Buchumenski I. Porath H.T. Danan-Gotthold M. Knisbacher B.A. Eisenberg E. Levanon E.Y. Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors Cell Rep. 2015 13 267 276 10.1016/j.celrep.2015.08.080 26440895 · DOI · Paper page
  126. Peng X. Xu X. Wang Y. Hawke D.H. Yu S. Han L. Zhou Z. Mojumdar K. Jeong K.J. Labrie M. A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer Cancer Cell 2018 33 817 828.e7 10.1016/j.ccell.2018.03.026 29706454 PMC5953833 · DOI · Paper page
  127. Sakurai M. Shiromoto Y. Ota H. Song C. Kossenkov A.V. Wickramasinghe J. Showe L.C. Skordalakes E. Tang H.Y. Speicher D.W. ADAR1 controls apoptosis of stressed cells by inhibiting Staufen1-mediated mRNA decay Nat. Struct. Mol. Biol. 2017 24 534 543 10.1038/nsmb.3403 28436945 PMC5461201 · DOI · Paper page
  128. Xu L.D. Öhman M. ADAR1 Editing and its Role in Cancer Genes 2018 10 12 10.3390/genes10010012 30585209 PMC6356570 · DOI
  129. Martinez H.D. Jasavala R.J. Hinkson I. Fitzgerald L.D. Trimmer J.S. Kung H.J. Wright M.E. RNA editing of androgen receptor gene transcripts in prostate cancer cells J. Biol. Chem. 2008 283 29938 29949 10.1074/jbc.M800534200 18708348 PMC2662061 · DOI · Paper page
  130. Chen L. Li Y. Lin C.H. Chan T.H. Chow R.K. Song Y. Liu M. Yuan Y.F. Fu L. Kong K.L. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma Nat. Med. 2013 19 209 216 10.1038/nm.3043 23291631 PMC3783260 · DOI · Paper page
  131. Valencia J.C. Egbukichi N. Erwin-Cohen R.A. Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity J. Interferon Cytokine Res. 2019 39 72 84 10.1089/jir.2018.0060 30562133 PMC6350415 · DOI
  132. Staege M.S. Emmer A. Editorial: Endogenous Viral Elements-Links Between Autoimmunity and Cancer? Front. Microbiol. 2018 9 3171 10.3389/fmicb.2018.03171 30619227 PMC6306460 · DOI
  133. Brütting C. Emmer A. Kornhuber M.E. Staege M.S. Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases BioMed Res. Int. 2017 2017 7973165 10.1155/2017/7973165 28326328 PMC5343228 · DOI
  134. Chen M. Hu S. Li Y. Jiang T.T. Jin H. Feng L. Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies Signal Transduct. Target. Ther. 2020 5 270 10.1038/s41392-020-00347-9 33214545 PMC7677403 · DOI
  135. Jin B. Cheng L.F. Wu K. Yu X.H. Yeo A.E. Application of dsRNA in cancer immunotherapy: Current status and future trends Anti-Cancer Agents Med. Chem. 2014 14 241 255 10.2174/18715206113136660373 24237222 · doi:10.2174/18715206113136660373
  136. Tsai H.C. Li H. Van Neste L. Cai Y. Robert C. Rassool F.V. Shin J.J. Harbom K.M. Beaty R. Pappou E. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells Cancer Cell 2012 21 430 446 10.1016/j.ccr.2011.12.029 22439938 PMC3312044 · DOI · Paper page
  137. Li H. Chiappinelli K.B. Guzzetta A.A. Easwaran H. Yen R.W. Vatapalli R. Topper M.J. Luo J. Connolly R.M. Azad N.S. Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers Oncotarget 2014 5 587 598 10.18632/oncotarget.1782 24583822 PMC3996658 · DOI · Paper page
  138. Banik D. Moufarrij S. Villagra A. Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy Int. J. Mol. Sci. 2019 20 2241 10.3390/ijms20092241 PMC6539010 31067680 · DOI · Paper page
  139. Covre A. Coral S. Nicolay H. Parisi G. Fazio C. Colizzi F. Fratta E. Di Giacomo A.M. Sigalotti L. Natali P.G. Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models Oncoimmunology 2015 4 e1019978 10.1080/2162402X.2015.1019978 26405573 PMC4570131 · DOI · Paper page
  140. Ammi R. De Waele J. Willemen Y. Van Brussel I. Schrijvers D.M. Lion E. Smits E.L. Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs Pharmacol. Ther. 2015 146 120 131 10.1016/j.pharmthera.2014.09.010 25281915 · DOI · Paper page
  141. Cheever M.A. Twelve immunotherapy drugs that could cure cancers Immunol. Rev. 2008 222 357 368 10.1111/j.1600-065X.2008.00604.x 18364014 · DOI · Paper page

Cited by

See all 70

Metadata

Authors
Sadeq, S., Al-Hashimi, S., Cusack, C. M., & Werner, A.
Affiliations
Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
Venue
Non-Coding RNA
Publisher
MDPI AG
Published
2021-02-19
Volume
7
Issue
1
Pages
15
ISSN
2311-553X
Cited by
70
References
15
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endogenous Double-Stranded RNA. https://app.cochat.ai/papers/10.3390/ncrna7010015
The paper
Sadeq, S., Al-Hashimi, S., Cusack, C. M., & Werner, A. (2021). Endogenous Double-Stranded RNA. Non-Coding RNA. https://doi.org/10.3390/ncrna7010015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.